Related Experiment Video
Updated: Dec 13, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to
Zhen Shu1,2, Zhen Li1,3, Huanhuan Huang4
1Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, 510632, China.
Abstract:
Ribonucleotide reductase (RNR) catalyzes the rate-limiting step of de novo synthesis of deoxyribonucleotide triphosphates (dNTPs) building blocks for DNA synthesis, and is a well-recognized target for cancer therapy. RNR is a heterotetramer consisting of two large RRM1 subunits and two small RRM2 subunits. RNR activity is greatly stimulated by transcriptional activation of RRM2 during S/G2 phase to ensure adequate dNTP supply for DNA replication. However, little is known about the cell-cycle-dependent regulation of RNR activity through RRM1. Here, we report that RRM1 is phosphorylated at Ser 559 by CDK2/cyclin A during S/G2 phase. And this S559 phosphorylation of RRM1enhances RNR enzymatic activity and is required for maintaining sufficient dNTPs during normal DNA replication. Defective RRM1 S559 phosphorylation causes DNA replication stress, double-strand break, and genomic instability. Moreover, combined targeting of RRM1 S559 phosphorylation and ATR triggers lethal replication stress and profound antitumor effects. Thus, this posttranslational phosphorylation of RRM1 provides an alternative mechanism to finely regulating RNR and therapeutic opportunities for cancer treatment.
Insights
Researchers discovered that phosphorylating Ribonucleotide reductase (RNR) subunit RRM1 at Serine 559 enhances DNA synthesis. This finding reveals a new mechanism for regulating RNR activity and offers novel cancer therapy strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Biology
Background:
- Ribonucleotide reductase (RNR) is crucial for DNA synthesis and a cancer therapy target.
- RNR activity is regulated by its subunits RRM1 and RRM2, with RRM2 regulation well-studied.
- Cell-cycle-dependent regulation of RNR via RRM1 remains largely unknown.
Purpose of the Study:
- To investigate the cell-cycle-dependent regulation of RNR activity through its RRM1 subunit.
- To identify posttranslational modifications of RRM1 and their functional consequences.
Main Methods:
- Phosphorylation site mapping of RRM1.
- Enzymatic activity assays.
- Cell-cycle analysis and DNA replication stress studies.
Main Results:
- RRM1 is phosphorylated at Serine 559 (S559) by CDK2/cyclin A during the S/G2 phase.
- S559 phosphorylation enhances RNR enzymatic activity, ensuring sufficient deoxyribonucleotide triphosphates (dNTPs) for DNA replication.
- Impaired RRM1 S559 phosphorylation leads to replication stress, DNA double-strand breaks, and genomic instability.
- Targeting RRM1 S559 phosphorylation with ATR inhibitors induces lethal replication stress and significant antitumor effects.
Conclusions:
- Posttranslational phosphorylation of RRM1 at S559 is a key mechanism for regulating RNR activity during the cell cycle.
- This regulation is essential for maintaining genomic stability.
- Targeting RRM1 S559 phosphorylation presents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Restarting Stalled Replication Forks
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Inhibition of Cdk Activity

